These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

603 related articles for article (PubMed ID: 16007582)

  • 41. [Hemolytic disease of the newborn caused by maternal allo-immunization against erythrocyte antigens other than A, B and rhesus D].
    Monestier M; Rigal D; Juron-Dupraz F; Meyer F
    J Gynecol Obstet Biol Reprod (Paris); 1984; 13(6):671-80. PubMed ID: 6520354
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Hemolytic disease of the newborn caused by anti-S antibodies].
    Maszkiewicz W; Osmeda-Launer H; Ornat K
    Pediatr Pol; 1982; 57(10):817-20. PubMed ID: 6892125
    [No Abstract]   [Full Text] [Related]  

  • 43. Prediction of ABO hemolytic disease of the newborn using pre- and perinatal quantification of maternal anti-A/anti-B IgG titer.
    Krog GR; Donneborg ML; Hansen BM; Lorenzen H; Clausen FB; Jensen KV; Kjærbye-Thygesen A; Albertsen P; Ebbesen F; Bergholt T; Smed MK; Dziegiel MH
    Pediatr Res; 2021 Jul; 90(1):74-81. PubMed ID: 33173174
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Value of thermo-resistant immune antibodies active against cord erythrocytes for the diagnosis of hemolytic disease of the newborn caused by ABO incompatibility].
    Ottaviano S; Menghetti E; Mencarini L; Carapella de Luca E
    Riv Ostet Ginecol; 1969 May; 24(5):163-70. PubMed ID: 5393391
    [No Abstract]   [Full Text] [Related]  

  • 45. [Clinical picture and the course of infection in hemolytic disease of the newborn].
    Maszkiewicz W; Koralewska J; Bokrzycka-Krysiak K; Kupiec G
    Acta Haematol Pol; 1988; 19(1-2):99-103. PubMed ID: 3149119
    [No Abstract]   [Full Text] [Related]  

  • 46. [Early determination of ABO incompatibility. Catamnestic studies of 141 pregnancies with suspicion or clinical evidence of ABO incompatibility].
    Kröger E; Scherbening G
    Munch Med Wochenschr; 1969 Nov; 111(46):2388-92. PubMed ID: 5394823
    [No Abstract]   [Full Text] [Related]  

  • 47. [Elution technics for the detection of antibodies in hemolytic disease of the newborn].
    Gota F; Dallavalle FM
    Arch Sci Med (Torino); 1980; 137(4):567-9. PubMed ID: 7018457
    [No Abstract]   [Full Text] [Related]  

  • 48. [Incidence of neonates treated with exchange transfusion for hemolytic disease due to ABO system incompatibility during the past 16 years].
    Hodr R; Zoban P; Hromádková L; Kepertová M; Skutilová J
    Cesk Pediatr; 1987 Aug; 42(8):464-6. PubMed ID: 3664755
    [No Abstract]   [Full Text] [Related]  

  • 49. [Immunologic and pathogenic problems posed by hemolytic diseases caused by Rhesus incompatibility of the firstborn infant].
    Gabriel H
    J Gynecol Obstet Biol Reprod (Paris); 1972; 1(5 Suppl 2):231-2. PubMed ID: 4220063
    [No Abstract]   [Full Text] [Related]  

  • 50. A simple method for the prediction of ABO incompatibility using Sephadex A-50. Prediction of ABO incompatibility.
    Graham H; Morrison M; MacAndrew R
    Vox Sang; 1975; 29(5):371-7. PubMed ID: 1199025
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [A case of a newborn infant with erythrocytes sensitized by anti-A 1 antibodies and absence of hematological and clinical findings of hemolytic disease].
    Scoppetta V
    Arch Ostet Ginecol; 1968; 73(3):391-6. PubMed ID: 4987886
    [No Abstract]   [Full Text] [Related]  

  • 52. [ABO incompatibility as the cause of the hemolytic disease in the newborn].
    Cohen M; Nelken D
    Harefuah; 1972 Feb; 82(4):190-1. PubMed ID: 5066107
    [No Abstract]   [Full Text] [Related]  

  • 53. [Hemolytic disease of the newborn due to anti-Kidd Jka sensitization during pregnancy].
    Mizutani T; Tanizawa O; Imai S; Suehara N; Takemura T; Wada Y; Fujita T; Kidoguchi K; Nakayama M
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 Oct; 41(10):1587-90. PubMed ID: 2584811
    [No Abstract]   [Full Text] [Related]  

  • 54. Haemolytic disease of the newborn caused by anti-MUT (MNS 35).
    van den Bos AG; Steiner K
    Vox Sang; 2004 Oct; 87(3):208-9. PubMed ID: 15569075
    [No Abstract]   [Full Text] [Related]  

  • 55. [Clinical severity of hemolytic disease of the newborn due to ABO incompatibility].
    Paz M; Shile R; Stanetzky J; Rikover M; Naor S
    Harefuah; 1972 Feb; 82(4):157-60. PubMed ID: 5052935
    [No Abstract]   [Full Text] [Related]  

  • 56. [Serology of ABO erythroblastosis].
    Speiser P
    Wien Med Wochenschr; 1966 Nov; 116(46):974-5. PubMed ID: 5989480
    [No Abstract]   [Full Text] [Related]  

  • 57. Prevalence and titre of ABO haemolysin antibodies in pregnant Nigerian women.
    Usanga EA; Akwiwu JO
    East Afr Med J; 1990 Jun; 67(6):437-41. PubMed ID: 2279474
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Correlation of Fc(gamma)RIIa (CD32) Polymorphism and IgG Antibody Subclasses in Hemolytic Disease of Newborn.
    Wu Q; Zhang Y; Liu M; Wang B; Liu S; He C
    Neonatology; 2009; 96(1):1-5. PubMed ID: 19129718
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Serological diagnosis of ABO-hemolytic disease in the newborn].
    Vulcheva VIa
    Akush Ginekol (Sofiia); 1974; 13(2):152-8. PubMed ID: 4839367
    [No Abstract]   [Full Text] [Related]  

  • 60. Haemolytic disease of the newborn due to ABO incompatibility. A new aid to diagnosis.
    Moores P; Grobbelaar BG; Ward V
    Acta Haematol; 1970; 44(1):47-51. PubMed ID: 4991327
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.